Clinical Trials Directory

Trials / Completed

CompletedNCT00753558

Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae

A Randomized,Double-Blind,Placebo-Controled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella Pneumoniae Carriage

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Soroka University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is an urgent need to control our current national outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP). The purpose of this study is to eradicate CRKP gastrointestinal carriage using selective digestive decontamination (SDD); with buccal and oral gentamicin and polymyxin E administration. This will reduce infections and hopefully mortality caused by CRKP.

Conditions

Interventions

TypeNameDescription
DRUGArm #1 :Oral solution and buccal gel of gentamicin and polymyxin E. Arm #2: Placebo.Arm #1: Oral gentamicin \& polymyxin E, gentamicin \& polymyxin E buccal gel. Arm #2: Oral placebo solutions, placebo buccal gel.

Timeline

Start date
2008-11-01
Primary completion
2010-06-01
Completion
2010-07-01
First posted
2008-09-16
Last updated
2010-09-21

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00753558. Inclusion in this directory is not an endorsement.